FedEx Express and today announce the global launch of Medpak VI°C, a service first launched in Europe that offers safe and reliable transportation of sensitive healthcare products.

　　Launched in Europe in 2016, Medpak VI°C is the innovative network solution that allows companies in the clinical trials sector to ship test medications in temperature-controlled, reuseable packaging. FedEx and are now rolling the service out internationally, starting with Asia-Pacific and North America.

　　Marking a significant development for the FedEx Express healthcare business, Medpak VI°C is also now serving customers in the pharmaceutical and medical device industries in addition to the clinical trials sector. These sectors all rely on excellence in temperature controlled technology to ship high-value and temperature-sensitive products.

　　“The international launch of Medpak VI°C to various healthcare sectors marks an important and exciting step forward for the FedEx Express and healthcare portfolio, as well as for integration of the two businesses,” said Roland Schütze, Healthcare Lead at FedEx Express and . “More than anything, our customers need reliability in terms of the technology itself, highly accurate delivery performance, time-sensitive shipment and having a partner that can deliver a full end-to-end service without multiple carriers and supported by a dedicated customer service team. I’m delighted that we’re able to take this innovation to the global marketplace.”

　　FedEx Express and began integrating in 2016 to offer customers a broader service portfolio and the benefits of access to the world’s largest air express network and an unparalleled road network. Medpak VI°C, originally a service, was made available to FedEx customers in Europe in 2018 and is now expanded globally.